CNS Pharmaceuticals, Inc. (CNSP) Operating income 2018–2025
CNS Pharmaceuticals, Inc. (CNSP) annual operating income history from SEC filings — each fiscal year as reported.
-$16.0MFY2025 · since FY2018: -$881,787 → -$16.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.0M | -7.3% |
| FY2024 | -$14.9M | +21.0% |
| FY2023 | -$18.9M | -23.6% |
| FY2022 | -$15.3M | -5.4% |
| FY2021 | -$14.5M | -53.2% |
| FY2020 | -$9.5M | -146.7% |
| FY2019 | -$3.8M | -334.7% |
| FY2018 | -$881,787 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CNSP financial trends
CNSP RevenueCNSP Net incomeCNSP Net marginCNSP Gross profitCNSP Gross marginCNSP Operating marginCNSP Operating cash flowCNSP Free cash flowCNSP Capital expendituresCNSP Return on equityCNSP Stock buybacksCNSP Dividends paidCNSP Total assetsCNSP Total liabilitiesCNSP Shareholders’ equityCNSP overview →